As of June 2026 ArriVent BioPharma has a market cap of โฌ1.21 Billion. This makes ArriVent BioPharma the world's 5492th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jun 11th, 2026 the market cap of ArriVent BioPharma was reported to be: